Clinical Topics & News

New Topical Treatments for Psoriasis

For the vast majority of psoriasis patients, topical medications still represent the mainstay of treatment. However, new agents can be added to the treatment armamentarium for psoriasis.


 

Vidyard Video

Recommended Reading

Comorbidities may cut effectiveness of psoriasis biologics
MDedge Dermatology
Guselkumab tops secukinumab over 48 weeks for plaque psoriasis
MDedge Dermatology
What’s New in Topical Treatments for Psoriasis
MDedge Dermatology
Psoriasis Treatment in Patients With Sickle Cell Disease
MDedge Dermatology
Safety and Efficacy of Halobetasol Propionate Lotion 0.01% in the Treatment of Moderate to Severe Plaque Psoriasis: A Pooled Analysis of 2 Phase 3 Studies
MDedge Dermatology
Clearance of Psoriasis After Ischemic Stroke
MDedge Dermatology
Different disease features found with family history of psoriasis versus PsA
MDedge Dermatology
Biologics curb coronary artery plaques in severe psoriasis
MDedge Dermatology
What’s new with adalimumab? Plenty
MDedge Dermatology
TNF inhibitor prices rose despite increased drug class competition
MDedge Dermatology